Back to results
US 12,678,487 B2Granted
Targeting lung-resident TNFR2+ cDC2 (R2D2) subpopulation to treat asthma
AssigneeUniversity of Florida Research Foundation, Inc.
InventorsLei Jin, Samira Mansouri
Life of this patent
Estimating the term…
Abstract
Provided herein are compositions and methods for treating an inflammatory respiratory disorder. Exemplified are corn-positions comprising interferon-beta of IFN-beta-fusion peptides.
Claims12
A method for treating asthma or chronic obstructive pulmonary disease (COPD), comprising administering by pulmonary or intranasal delivery to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of interferon-beta (IFNB) or an IFNB fusion protein, wherein the IFNB or the IFNB fusion protein comprises the sequence of SEQ ID NO:
- 2 or SEQ ID NO:
- 3.
Dependencies are inferred from the claim text.